Table 1 . summary Distribution of all variables ,Groupwise

variable FENTOFOL KETOFOL P value
AGE Mean (SD) 39.9 (9.8) 40.9 (11.0) 0.341
SEX Female 21 (52.5) 23 (57.5) 0.653
Male 19 (47.5) 17 (42.5)
MOUTH_OPENING Full 35 (87.5) 37 (92.5) 0.456
Partial 5 (12.5) 3 (7.5)
COUGHING Mild 2 (5.0) 4 (10.0) 0.396
Nil 38 (95.0) 36 (90.0)
SWALLOWING Nil 40 (100.0) 40 (100.0) NA
EASE_OF_INSERTION Difficult 1 (2.5) 2 (5.0) 0.556
Easy 39 (97.5) 38 (95.0)
MOVEMENT Mild 12 (30.0) 14 (35.0) 0.556
Nil 27 (67.5) 26 (65.0)
Severe 1 (2.5) 0 (0.0)
LARYNGOSPASM Nil 40 (100.0) 40 (100.0) NA
APNEA Apnea 35 (87.5) 0 (0.0) <0.001
No_Apnea 5 (12.5) 40 (100.0)
ADDITIONAL_PROPOFOL_REQUIRED No 29 (72.5) 37 (92.5) 0.019
Yes 11 (27.5) 3 (7.5)
LMA_INSERTION_SCORE 6 12 (30.0) 6 (15.0) 0.020
7 23 (57.5) 19 (47.5)
8 1 (2.5) 10 (25.0)
9 4 (10.0) 5 (12.5)
SBP_BEFORE_INDUCTION Mean (SD) 128.8 (8.7) 125.5 (8.2) 0.124
SBP_AFTER_INTERVENTION Mean (SD) 127.6 (8.9) 128.0 (8.6) 0.992
SBP_AFTER_PROPOFOL Mean (SD) 112.8 (9.8) 118.3 (8.9) 0.013
SBP_AFTER_LMA Mean (SD) 104.7 (9.3) 133.6 (11.4) <0.001
SBP_1_MIN Mean (SD) 97.4 (8.4) 125.9 (8.6) <0.001
SBP_2_MIN Mean (SD) 106.8 (10.1) 124.6 (9.5) <0.001
SBP_3_MIN Mean (SD) 108.9 (9.6) 119.3 (8.5) <0.001
DBP_1_MIN Mean (SD) 70.1 (4.2) 86.6 (4.2) <0.001
DBP_2_MIN Mean (SD) 74.8 (4.7) 86.3 (4.6) <0.001
DBP_3_MIN Mean (SD) 78.4 (4.8) 85.5 (4.4) <0.001
DBP_AFTER_INTERVENTION Mean (SD) 86.3 (5.2) 88.7 (4.3) 0.066
DBP_AFTER_LMA Mean (SD) 72.8 (5.1) 87.7 (5.5) <0.001
DBP_AFTER_PROPOFOL Mean (SD) 80.0 (4.8) 83.5 (4.8) 0.002
DBP_BEFORE_INDUCTION Mean (SD) 89.2 (4.1) 89.0 (4.1) 0.996
PR_BEFORE_INDUCTION Mean (SD) 71.1 (8.6) 72.1 (8.3) 0.643
PR_AFTER_INTERVENTION Mean (SD) 68.0 (8.9) 78.4 (8.5) <0.001
PR_AFTER_PROPOFOL Mean (SD) 64.4 (9.8) 73.8 (9.0) <0.001
PR_AFTER_LMA Mean (SD) 75.1 (9.2) 106.0 (11.4) <0.001
PR_1_MIN Mean (SD) 67.9 (8.5) 88.4 (8.6) <0.001
PR_2_MIN Mean (SD) 64.2 (10.2) 81.2 (9.5) <0.001
PR_3_MIN Mean (SD) 59.4 (9.6) 75.0 (8.5) <0.001
MAP_BEFORE_INDUCTION Mean (SD) 89.2 (4.1) 89.0 (4.1) 0.996
MAP_AFTER_INTERVENTION Mean (SD) 86.3 (5.2) 88.7 (4.3) 0.066
MAP_AFTER_PROPOFOL Mean (SD) 80.0 (4.8) 83.5 (4.8) 0.002
MAP_AFTER_LMA Mean (SD) 72.8 (5.1) 87.7 (5.5) <0.001
MAP_1_MIN Mean (SD) 70.1 (4.2) 86.6 (4.2) <0.001
MAP_2_MIN Mean (SD) 74.8 (4.7) 86.3 (4.6) <0.001
MAP_3_MIN Mean (SD) 78.4 (4.8) 85.5 (4.4) <0.001
RR_BEFORE_INDUCTION 11 7 (17.5) 13 (32.5) 0.129
12 28 (70.0) 18 (45.0)
13 5 (12.5) 8 (20.0)
14 0 (0.0) 1 (2.5)
RR_AFTER_INTERVENTION 8 2 (5.0) 0 (0.0) <0.001
9 4 (10.0) 0 (0.0)
10 6 (15.0) 0 (0.0)
11 7 (17.5) 5 (12.5)
12 8 (20.0) 30 (75.0)
13 4 (10.0) 5 (12.5)
14 5 (12.5) 0 (0.0)
15 3 (7.5) 0 (0.0)
16 1 (2.5) 0 (0.0)
RR_AFTER_PROPOFOL 9 2 (5.0) 0 (0.0) 0.092
10 6 (15.0) 2 (5.0)
11 6 (15.0) 15 (37.5)
12 11 (27.5) 14 (35.0)
13 10 (25.0) 5 (12.5)
14 4 (10.0) 4 (10.0)
15 1 (2.5) 0 (0.0)
RR_AFTER_LMA 11 1 (2.5) 0 (0.0) 0.001
12 3 (7.5) 1 (2.5)
13 12 (30.0) 4 (10.0)
14 13 (32.5) 3 (7.5)
15 7 (17.5) 10 (25.0)
16 3 (7.5) 11 (27.5)
17 1 (2.5) 5 (12.5)
18 0 (0.0) 4 (10.0)
19 0 (0.0) 2 (5.0)
RR_1_MIN 12 11 (27.5) 0 (0.0) <0.001
13 21 (52.5) 4 (10.0)
14 8 (20.0) 12 (30.0)
15 0 (0.0) 14 (35.0)
16 0 (0.0) 7 (17.5)
17 0 (0.0) 3 (7.5)
RR_2_MIN 11 13 (32.5) 0 (0.0) <0.001
12 19 (47.5) 5 (12.5)
13 6 (15.0) 33 (82.5)
14 2 (5.0) 2 (5.0)
RR_3_MIN 10 3 (7.5) 0 (0.0) 0.013
11 19 (47.5) 11 (27.5)
12 10 (25.0) 21 (52.5)
13 5 (12.5) 8 (20.0)
14 3 (7.5) 0 (0.0)
SpO2_BEFORE_INDUCTION 97 0 (0.0) 1 (2.5) 0.446
98 5 (12.5) 3 (7.5)
99 6 (15.0) 10 (25.0)
100 29 (72.5) 26 (65.0)
SpO2_AFTER_INTERVENTION 97 1 (2.5) 0 (0.0) 0.767
98 3 (7.5) 4 (10.0)
99 6 (15.0) 6 (15.0)
100 30 (75.0) 30 (75.0)
SpO2_AFTER_PROPOFOL 98 1 (2.5) 1 (2.5) 0.767
99 14 (35.0) 11 (27.5)
100 25 (62.5) 28 (70.0)
SpO2_AFTER_LMA 97 1 (2.5) 0 (0.0) 0.234
98 5 (12.5) 1 (2.5)
99 7 (17.5) 10 (25.0)
100 27 (67.5) 29 (72.5)
SpO2_1_MIN 97 2 (5.0) 0 (0.0) 0.126
98 3 (7.5) 0 (0.0)
99 11 (27.5) 10 (25.0)
100 24 (60.0) 30 (75.0)
SpO2_2_MIN 97 1 (2.5) 0 (0.0) 0.060
98 4 (10.0) 0 (0.0)
99 7 (17.5) 14 (35.0)
100 28 (70.0) 26 (65.0)
SpO2_3_MIN 97 2 (5.0) 0 (0.0) 0.046
98 4 (10.0) 0 (0.0)
99 8 (20.0) 5 (12.5)
100 26 (65.0) 35 (87.5)

Demographic Variables

Distribution of Demographic Variables in Our Population

Age

Fig.1 Plot of Age distribution across Groups

The Dodged bar chart above represents individual counts representing frequency of age_grp categories 30-40,50-60,40-50,20-30,10-20 and 60-70 in categories FENTOFOL and KETOFOL Subgroups. Age Group group 30-40 has highest percentage 16/40 ( 40 % ) in group FENTOFOL . Subgroup 40-50 has highest percentage 15/40 ( 37.5 % ) in group KETOFOL . To formally check for association between groups we performed pearson chi-square test .

we found a Non-significant association between age_grp and DRUG. The chi-square statistic was 5.44 . The degree of freedom was 5 and P value was 0.36 .Contingency and Proportion table are shown below.

Table 2

DRUG age_grp n value 95 % Confidence Interval
FENTOFOL 10-20 1 1/40 ( 2.5 %) 0.27% - 11.09%
FENTOFOL 20-30 5 5/40 ( 12.5 %) 4.93% - 25.25%
FENTOFOL 30-40 16 16/40 ( 40 %) 25.95% - 55.44%
FENTOFOL 40-50 13 13/40 ( 32.5 %) 19.6% - 47.84%
FENTOFOL 50-60 4 4/40 ( 10 %) 3.47% - 22.04%
FENTOFOL 60-70 1 1/40 ( 2.5 %) 0.27% - 11.09%
KETOFOL 10-20 3 3/40 ( 7.5 %) 2.16% - 18.68%
KETOFOL 20-30 5 5/40 ( 12.5 %) 4.93% - 25.25%
KETOFOL 30-40 9 9/40 ( 22.5 %) 11.76% - 37.06%
KETOFOL 40-50 15 15/40 ( 37.5 %) 23.79% - 52.95%
KETOFOL 50-60 8 8/40 ( 20 %) 9.94% - 34.22%

Table 3

FENTOFOL KETOFOL
10-20 1 3
20-30 5 5
30-40 16 9
40-50 13 15
50-60 4 8
60-70 1 0

Gender

Figure 2 Sex Distribution in Our Population

The Dodged bar chart above represents individual counts representing frequency of SEX categories Female and Male in categories FENTOFOL and KETOFOL . To formally check for association between groups we performed pearson chi-square test

we found a Non-significant association between SEX and CO-INDUCTION Agent. The chi-square statistic was 0.05 . The degree of freedom was 1 and P value was 0.82 .Contingency and Proportion table are shown below

Table 4

DRUG SEX n value 95 % Confidence Interval
FENTOFOL Female 21 21/40 ( 52.5 %) 37.3% - 67.35%
FENTOFOL Male 19 19/40 ( 47.5 %) 32.65% - 62.7%
KETOFOL Female 23 23/40 ( 57.5 %) 42.1% - 71.85%
KETOFOL Male 17 17/40 ( 42.5 %) 28.15% - 57.9%

Table 5

FENTOFOL KETOFOL
Female 21 23
Male 19 17

Outcomes Of Interest

Effect On systolic Blood Pressure

Figure 3 Trace-Plot Of variation in Systolic BP with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Systolic BP (on Y axis) with passage of of time of LMA insertion on X-axis , Systolic BP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.

we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in Systolic BP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Systolic BP across groups varies with Time. . we decided to explore this intuitive graphical relationship with formal statistical tests.

.Two way repeated measures ANOVA was done to assess difference between average Systolic BP across Stages/time of LMA Insertion group and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of value within t Stages/time of LMA Insertion was affected by Drug. Inter group comparison of average difference between SBP of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 50.08,p= 0.0001. Intra group comparison of average difference between value of SBP across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 130.38,p= 0.0001. Interaction of SBP within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 133.66,p= 0.0001

Since Inter group average differences of Systolic BP between 2 DRUG Groups was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -12.61+-1.78, pvalue= <0.001. Table of means/standard errors and contrasts is presented below.

Table 6. Average Systolic BP, standard error and 95% Confidence limits in DRUG Groups

Drug Mean Standard_Error lower.CL upper.CL
FENTOFOL 112.418 1.26 109.910 114.926
KETOFOL 125.025 1.26 122.517 127.533

Table 7. Average Contrast in Systolic BP within DRUG Groups

contrast estimate SE df t.ratio p.value
FENTOFOL - KETOFOL -12.607 1.781 78 -7.077 0

We also wanted to look for a trend in our Stages/time of LMA Insertion group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with Stages/time of LMA Insertion, (-67.29+-2.96) , p value= <0.001. It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in systolic BP with Stages/time of LMA Insertion (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups,Followed by a rise. In KetoFol group Systolic BP remains relatively steady. Table of means/standard errors and contrasts is presented below.

Table 8. Average Systolic BP, standard error and 95% Confidence limits in various Satges Of LMA Insertion

time Mean Standard_Error lower.CL upper.CL
Before.Induction 127.138 1.03 125.101 129.174
After.Intervention 127.800 1.03 125.763 129.837
After.propofol 115.588 1.03 113.551 117.624
After.LMA 119.100 1.03 117.063 121.137
1.min 111.638 1.03 109.601 113.674
2.min 115.688 1.03 113.651 117.724
3.min 114.100 1.03 112.063 116.137

Table 9. Average Contrast in Systolic BP within all Subgroups of Stages of LMA Insertion

contrast estimate SE df t.ratio p.value
Before.Induction - After.Intervention -0.662 0.79 468 -0.839 0.981
Before.Induction - After.propofol 11.550 0.79 468 14.625 0.001
Before.Induction - After.LMA 8.038 0.79 468 10.177 0.001
Before.Induction - 1.min 15.500 0.79 468 19.626 0.001
Before.Induction - 2.min 11.450 0.79 468 14.498 0.001
Before.Induction - 3.min 13.038 0.79 468 16.508 0.001
After.Intervention - After.propofol 12.213 0.79 468 15.463 0.001
After.Intervention - After.LMA 8.700 0.79 468 11.016 0.001
After.Intervention - 1.min 16.163 0.79 468 20.465 0.001
After.Intervention - 2.min 12.112 0.79 468 15.337 0.001
After.Intervention - 3.min 13.700 0.79 468 17.347 0.001
After.propofol - After.LMA -3.513 0.79 468 -4.448 0.001
After.propofol - 1.min 3.950 0.79 468 5.001 0.001
After.propofol - 2.min -0.100 0.79 468 -0.127 1
After.propofol - 3.min 1.487 0.79 468 1.883 0.492
After.LMA - 1.min 7.463 0.79 468 9.449 0.001
After.LMA - 2.min 3.413 0.79 468 4.321 0.001
After.LMA - 3.min 5.000 0.79 468 6.331 0.001
1.min - 2.min -4.050 0.79 468 -5.128 0.001
1.min - 3.min -2.463 0.79 468 -3.118 0.032
2.min - 3.min 1.587 0.79 468 2.010 0.41

Effect On Diastolic Blood Pressure

Figure 4 Trace-Plot Of variation in Diastolic BP with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Diastolic BP (on Y axis) with passage of of time of LMA insertion on X-axis , Diastolic BP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.

we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in Diastolic BP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Diastolic BP across groups varies with Time. . we decided to explore this intuitive graphical relationship with formal statistical tests.

Two way repeated measures ANOVA was done to assess difference between average value of DBP across Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of DBP within Stages/time of LMA Insertion time was affected by Drug. Inter group comparison of average difference of DBP between 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 27.91,p= 0.0001. Intra group comparison of average difference between DBP across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 117.71,p= 0.0001. Interaction of DBP within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 32.47,p= 0.0001

Since Intra group average differences of value between 2 DRUGS was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -5.6+-1.06, pvalue= <0.001

Table 10. Average Diastolic BP, standard error and 95% Confidence limits in DRUG Groups

Drug Mean Standard_Error lower.CL upper.CL
FENTOFOL 62.029 0.749 60.537 63.520
KETOFOL 67.625 0.749 66.134 69.116

Table 11. Average Contrast in Diastolic BP within DRUG Groups

contrast estimate SE df t.ratio p.value
FENTOFOL - KETOFOL -5.596 1.059 78 -5.283 0

We also wanted to look for a trend in our time group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with Stages/time of LMA Insertion , (-24.72+-1.6, p value= <0.001). It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Diastolic BP with Time (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups( though lesser as compared to Systolic BP) ,Followed by a rise. In KetoFol group Diastolic BP remains relatively steady. Table of means/standard errors and contrasts is presented below.

Table 12. Average Diastolic BP, standard error and 95% Confidence limits in various Satges Of LMA Insertion

time Mean Standard_Error lower.CL upper.CL
Before.Induction 70.113 0.599 68.927 71.298
After.Intervention 67.388 0.599 66.202 68.573
After.propofol 64.863 0.599 63.677 66.048
After.LMA 60.875 0.599 59.690 62.060
1.min 61.713 0.599 60.527 62.898
2.min 62.975 0.599 61.790 64.160
3.min 65.863 0.599 64.677 67.048

Table 13. Average Contrast in Diatolic BP within all Subgroups of Stages of LMA Insertion

contrast estimate SE df t.ratio p.value
Before.Induction - After.Intervention 2.725 0.427 468 6.385 0.001
Before.Induction - After.propofol 5.250 0.427 468 12.302 0.001
Before.Induction - After.LMA 9.237 0.427 468 21.645 0.001
Before.Induction - 1.min 8.400 0.427 468 19.683 0.001
Before.Induction - 2.min 7.137 0.427 468 16.725 0.001
Before.Induction - 3.min 4.250 0.427 468 9.959 0.001
After.Intervention - After.propofol 2.525 0.427 468 5.917 0.001
After.Intervention - After.LMA 6.512 0.427 468 15.260 0.001
After.Intervention - 1.min 5.675 0.427 468 13.298 0.001
After.Intervention - 2.min 4.412 0.427 468 10.339 0.001
After.Intervention - 3.min 1.525 0.427 468 3.573 0.007
After.propofol - After.LMA 3.987 0.427 468 9.344 0.001
After.propofol - 1.min 3.150 0.427 468 7.381 0.001
After.propofol - 2.min 1.888 0.427 468 4.423 0.001
After.propofol - 3.min -1.000 0.427 468 -2.343 0.226
After.LMA - 1.min -0.837 0.427 468 -1.962 0.44
After.LMA - 2.min -2.100 0.427 468 -4.921 0.001
After.LMA - 3.min -4.988 0.427 468 -11.687 0.001
1.min - 2.min -1.263 0.427 468 -2.958 0.05
1.min - 3.min -4.150 0.427 468 -9.724 0.001
2.min - 3.min -2.888 0.427 468 -6.766 0.001

Effect On Pulse Rate

Figure 5 Trace-Plot Of variation in Pulse Rate with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Pulse Rate (on Y axis) with passage of of time of LMA insertion on X-axis , Mean Pulse Rate readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . The connected points across the trace represent the mean readings in two groups and Box Plots represents Distribution of Pulse Rates in two groups.

we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Pulse Rate across groups varies with Time. Pulse Rate at end of 3 minutes post LMA insertion appears higher in Ketofol Group than Baseline. we decided to explore this intuitive graphical relationship with formal statistical tests.

wo way repeated measures ANOVA was done to assess difference between average value of Pulse rate in Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of value within time was affected by Drug.
Inter group comparison of average difference between Pulse Rate of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 70.38,p= 0.0001. Intra group comparison of average difference between Pulse rate across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 195.74,p= 0.0001. Interaction of Pulse rate within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 71.44,p= 0.0001

Since Intra group average differences of Pulse Rate between 2 Drugs was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -14.97+-1.78, pvalue= <0.001

Table 14. Average Pulse Rate, standard error and 95% Confidence limits in DRUG Groups

Drug Mean Standard_Error lower.CL upper.CL
FENTOFOL 67.150 1.262 64.638 69.662
KETOFOL 82.118 1.262 79.606 84.630

Table 15. Average Contrast in Pulse Rate within DRUG Groups

contrast estimate SE df t.ratio p.value
FENTOFOL - KETOFOL -14.968 1.784 78 -8.389 0

We also wanted to look for a trend in Pulse rate in Stages/time of LMA Insertion since it had a time varying component .We found a non-significant linear trend in intra-group difference with time , (-5.35+-2.96, p value= 0.071). It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Pulse Rate with Time (p value= <0.001). The non-linear trend is apparent in plot as well(Clear rise post LMA insertion in both groups followed by subsequent Fall) and it overwhems a linear trend unlike Systolic and Diastolic BP variation where linear trend was visible.. Table of means/standard errors and contrasts is presented below.

Table 16. Average Pulse Rate, standard error and 95% Confidence limits in various Satges Of LMA Insertion

time Mean Standard_Error lower.CL upper.CL
Before.Induction 71.600 1.031 69.561 73.639
After.Intervention 73.213 1.031 71.173 75.252
After.propofol 69.113 1.031 67.073 71.152
After.LMA 90.538 1.031 88.498 92.577
1.min 78.125 1.031 76.086 80.164
2.min 72.688 1.031 70.648 74.727
3.min 67.163 1.031 65.123 69.202

Table 17. Average Contrast in Pulse Rate within all Subgroups of Stages of LMA Insertion

contrast estimate SE df t.ratio p.value
Before.Induction - After.Intervention -1.613 0.79 468 -2.041 0.39
Before.Induction - After.propofol 2.487 0.79 468 3.149 0.029
Before.Induction - After.LMA -18.938 0.79 468 -23.973 0.001
Before.Induction - 1.min -6.525 0.79 468 -8.260 0.001
Before.Induction - 2.min -1.088 0.79 468 -1.377 0.814
Before.Induction - 3.min 4.437 0.79 468 5.617 0.001
After.Intervention - After.propofol 4.100 0.79 468 5.190 0.001
After.Intervention - After.LMA -17.325 0.79 468 -21.932 0.001
After.Intervention - 1.min -4.913 0.79 468 -6.219 0.001
After.Intervention - 2.min 0.525 0.79 468 0.665 0.994
After.Intervention - 3.min 6.050 0.79 468 7.659 0.001
After.propofol - After.LMA -21.425 0.79 468 -27.122 0.001
After.propofol - 1.min -9.013 0.79 468 -11.409 0.001
After.propofol - 2.min -3.575 0.79 468 -4.526 0.001
After.propofol - 3.min 1.950 0.79 468 2.469 0.173
After.LMA - 1.min 12.413 0.79 468 15.713 0.001
After.LMA - 2.min 17.850 0.79 468 22.596 0.001
After.LMA - 3.min 23.375 0.79 468 29.591 0.001
1.min - 2.min 5.438 0.79 468 6.883 0.001
1.min - 3.min 10.963 0.79 468 13.878 0.001
2.min - 3.min 5.525 0.79 468 6.994 0.001

Effect On Mean Arterial Blood Pressure

Figure 6 Trace-Plot Of variation in Mean Arterial BP with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Mean Arterial Pressure (on Y axis) with passage of of time of LMA insertion on X-axis , MAP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.

we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in MAP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Diastolic BP across groups varies with Time. MAP in KetoFol group appear to be relatively stable . we decided to explore this intuitive graphical relationship with formal statistical tests.

Two way repeated measures ANOVA was done to assess difference between average value of MAP across Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of MAP within Stages/time of LMA Insertion was affected by Drug. Inter group comparison of average difference between MAP of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 76.19,p= 0.0001. Intra group comparison of average difference between MAP with Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 213.82,p= 0.0001. Interaction of MAP within time with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 142.29,p= 0.0001

Since Intra group average differences of MAP between 2 Drugs was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -7.93+-0.91, pvalue= <0.001

Table 18. Average MAP, standard error and 95% Confidence limits in DRUG Groups

Drug Mean Standard_Error lower.CL upper.CL
FENTOFOL 78.825 0.643 77.545 80.104
KETOFOL 86.758 0.643 85.479 88.038

Table 19. Average Contrast in MAP within DRUG Groups

contrast estimate SE df t.ratio p.value
FENTOFOL - KETOFOL -5.596 1.059 78 -5.283 0

We also wanted to look for a trend of MAP in Stages/time of LMA Insertion our time group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with time ,() -38.91+-1.44, p value= <0.001).It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in MAP with Time (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups( and MAP continues to fall in FEntoFol Group ,Followed by a late) rise. In KetoFol group MAP remains relatively steady. Table of means/standard errors and contrasts is presented below.

Table 20. Average MAP, standard error and 95% Confidence limits in various Satges Of LMA Insertion

time Mean Standard_Error lower.CL upper.CL
Before.Induction 89.12 0.52 88.09 90.15
After.Intervention 87.53 0.52 86.50 88.55
After.propofol 81.77 0.52 80.74 82.80
After.LMA 80.28 0.52 79.26 81.31
1.min 78.35 0.52 77.33 79.38
2.min 80.55 0.52 79.52 81.57
3.min 81.94 0.52 80.91 82.97

Table 21. Average Contrast in MAP within all Subgroups of Stages of LMA Insertion

contrast estimate SE df t.ratio p.value
Before.Induction - After.Intervention 1.596 0.385 468 4.141 0.001
Before.Induction - After.propofol 7.350 0.385 468 19.073 0.001
Before.Induction - After.LMA 8.838 0.385 468 22.934 0.001
Before.Induction - 1.min 10.766 0.385 468 27.939 0.001
Before.Induction - 2.min 8.575 0.385 468 22.253 0.001
Before.Induction - 3.min 7.179 0.385 468 18.631 0.001
After.Intervention - After.propofol 5.754 0.385 468 14.932 0.001
After.Intervention - After.LMA 7.242 0.385 468 18.793 0.001
After.Intervention - 1.min 9.171 0.385 468 23.798 0.001
After.Intervention - 2.min 6.979 0.385 468 18.112 0.001
After.Intervention - 3.min 5.583 0.385 468 14.490 0.001
After.propofol - After.LMA 1.488 0.385 468 3.861 0.002
After.propofol - 1.min 3.417 0.385 468 8.866 0.001
After.propofol - 2.min 1.226 0.385 468 3.180 0.026
After.propofol - 3.min -0.171 0.385 468 -0.442 0.999
After.LMA - 1.min 1.929 0.385 468 5.006 0.001
After.LMA - 2.min -0.262 0.385 468 -0.681 0.994
After.LMA - 3.min -1.658 0.385 468 -4.303 0.001
1.min - 2.min -2.191 0.385 468 -5.686 0.001
1.min - 3.min -3.587 0.385 468 -9.309 0.001
2.min - 3.min -1.396 0.385 468 -3.623 0.006

Effect On Respiratory Rate

Figure 7 Trace-Plot Of variation in Mean Arterial BP with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Respiratory Rate (on Y axis) with passage of of time of LMA insertion on X-axis , RR readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.

we can clearly see a positive trend/slope indicating a transient rise with passage of Time in both groups. The difference between two Drug Groups appears significant,we can also see different slopes of variation of Respiratory Rate with Time between Fentofol and KetoFol groups indicating average difference in RR across groups varies with Time. (Rise is more acute in KetoFol group and Fall as well) we decided to explore this intuitive graphical relationship with formal statistical tests.

Two way repeated measures ANOVA was done to assess difference between average Respiratory Rate with and if there was inter-group differences between Drug . An interaction test was also conducted to see if inter-group variation of Respiratory Rate across Stages/time of LMA Insertion was affected by Drug. Since Sphericity (homogeneity of variance between pairs of intra-group comparisons) assumption was not met.Greenhouse-Geisser Correction was applied . Inter group comparison of average difference between Respiratory rate of Drugs(Ketofol and FentoFol) was significant with a p value of 0.0003 . In Formal statistical notation it is expressed as F(1, 78) = 14.62,p= 0.0003. Intra group comparison of average difference between Respiratory Rate within Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 208.36,p= 0.0001. Interaction of Respiratory Rate within time with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 25.59,p= 0.0001

Since Intra group average differences of Respiratory Rate between Drug groups was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -0.74+-0.19, pvalue= <0.001

Table 22. Average Respiratory Rate, standard error and 95% Confidence limits in DRUG Groups

Drug Mean Standard_Error lower.CL upper.CL
FENTOFOL 12.279 0.137 12.006 12.551
KETOFOL 13.018 0.137 12.746 13.290

Table 23. Average Contrast in Respiratory Rate between DRUG Groups

contrast estimate SE df t.ratio p.value
FENTOFOL - KETOFOL -0.739 0.193 78 -3.823 0

we also wanted to look for a trend in Respiratory Rate across Stages/time of LMA Insertion since it had a time varying component .We found a significant positive linear trend in intra-group difference in Respiratory with time , 2.69+-0.44, p value= <0.001.t was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Respiratory Rate with Time (p value= <0.001).Table of means/standard errors and contrasts is presented below.

Table 24. Average RR, standard error and 95% Confidence limits in various Satges Of LMA Insertion

time Mean Standard_Error lower.CL upper.CL
Before.Induction 11.94 0.12 11.69 12.18
After.Intervention 11.85 0.12 11.61 12.09
After.propofol 11.89 0.12 11.64 12.13
After.LMA 14.78 0.12 14.53 15.02
1.min 13.88 0.12 13.63 14.12
2.min 12.43 0.12 12.18 12.67
3.min 11.79 0.12 11.54 12.03

Table 25. Average Contrast in Respiratory Rate within all Subgroups of Stages of LMA Insertion

contrast estimate SE df t.ratio p.value
Before.Induction - After.Intervention 0.087 0.117 468 0.749 0.989
Before.Induction - After.propofol 0.050 0.117 468 0.428 1
Before.Induction - After.LMA -2.838 0.117 468 -24.276 0.001
Before.Induction - 1.min -1.938 0.117 468 -16.576 0.001
Before.Induction - 2.min -0.488 0.117 468 -4.171 0.001
Before.Induction - 3.min 0.150 0.117 468 1.283 0.859
After.Intervention - After.propofol -0.037 0.117 468 -0.321 1
After.Intervention - After.LMA -2.925 0.117 468 -25.025 0.001
After.Intervention - 1.min -2.025 0.117 468 -17.325 0.001
After.Intervention - 2.min -0.575 0.117 468 -4.919 0.001
After.Intervention - 3.min 0.063 0.117 468 0.535 0.998
After.propofol - After.LMA -2.887 0.117 468 -24.704 0.001
After.propofol - 1.min -1.988 0.117 468 -17.004 0.001
After.propofol - 2.min -0.537 0.117 468 -4.599 0.001
After.propofol - 3.min 0.100 0.117 468 0.856 0.979
After.LMA - 1.min 0.900 0.117 468 7.700 0.001
After.LMA - 2.min 2.350 0.117 468 20.105 0.001
After.LMA - 3.min 2.988 0.117 468 25.560 0.001
1.min - 2.min 1.450 0.117 468 12.405 0.001
1.min - 3.min 2.088 0.117 468 17.860 0.001
2.min - 3.min 0.638 0.117 468 5.454 0.001

Effect On Saturation

Figure 8 Trace-Plot Of variation in Oxygen Saturation with Time in FentoFol and Ketofol groups

This is a trace-plot of variation in Oxygen saturation (on Y axis) with passage of of time of LMA insertion on X-axis , Oxygen Saturation readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.

We cant see a definite trend in variation of oxygen Saturation as there is lot of random variation. we decided to explore this intuitive graphical relationship with formal statistical tests.

Two way repeated measures ANOVA was done to assess difference between average Saturation with passage of of time and if there was differences in oxygen saturation between 2 Drugs . An interaction test was also conducted to see if inter-group variation of Oxygen Saturation within Stages/time of LMA Insertion was affected by Drug. Since Sphericity (homogeneity of variance between pairs of intra-group comparisons) assumption was not met.Greenhouse-Geisser Correction was applied Inter group comparison of average difference between Oxygen saturation of 2 Drugs was non-significant with a p value of 0.190 . In Formal statistical notation it is expressed as F(1, 78) = 1.78,p= 0.190. Intra group comparison of average difference between value of time was non-significant with a p value of 0.830 . Since There was no significant difference within Drug groups or with passage of time (p=0.7) we didnt explore it further.

Other clinical parameters

LMA Insertion Score

Figure 9 Boxplot Of Distribution Of LMA Insertion Score in our Population

In this Figure we see Box plot of LMA_INSERTION_SCORE in 2 sub-groups of DRUG : FENTOFOL and KETOFOL respectively .The individual jittered data points of LMA_INSERTION_SCORE are overlaid over transparent Boxplot for better visualisation. We see distribution of data in individual sub-groups of DRUG based on these box-plots. The lower edge of box plot represents -first quartile (Q1), Horizontal bar represents the median, Upper edge represnts third quartile (Q3), Two black lines (whiskers) emanating from box-plots signify range of non-outlier data for the particular sub-group. Lower whisker represents minimum(Q1- 1.5 interquartile range) non-outlier limit of LMA_INSERTION_SCORE and upper whisker represnts maximum(Q1+1.5interquartile range) of LMA_INSERTION_SCORE .Any data beyond whiskers of box-plots represents outliers in the sub-groups The big brown point in the box-plots represents mean LMA_INSERTION_SCORE of 2 groups and it has been annotated in the figure itself . Summary Statistics of the groups is presented in table below

Table 26 Summary Table Of LMA INSERTION SCORE within Groups

Group n Mean SD Median Minimum Maximum
FENTOFOL 40 6.925 0.859 7 6 9
KETOFOL 40 7.350 0.893 7 6 9

We formally performed a Welch’s independent Sample T test between Two Groups. The mean in FENTOFOL [ 6.9 ± 0.85 ] was significantly lower than KETOFOL Group [ 7.35 ± 0.89] . The mean difference was 0.425 . The p value was <0.03 . The t statistic was 2.116 and degree of freedom of the Welch unpaired two-sample t test was 77.88 .In Formal statistical notation this result is expressed as : t(77.88) = 2.16, p= 0.0331. The detailed statistical parameters of T test are given in table below.

TABLE 27

variable group1 group2 statistic df p
LMA_INSERTION_SCORE FENTOFOL KETOFOL -2.17 77.88 0.03

APNEA

Figure 10 Distribution Of APNEA IN TWO GROUPS

The Grouped Pie chart above represents individual counts representing frequency of APNEA categories Apnea and No_Apnea in categories FENTOFOL and KETOFOL . Subgroup No_Apnea has highest percentage 31/40 ( 78 % ) in group FENTOFOL . Subgroup No_Apnea has highest percentage 40/40 ( 100 % ) in group KETOFOL . To formally check for association between groups we performed pearson chi-square test .

we found a Significant association between APNEA and DRUG. The chi-square statistic was 8.01 . The degree of freedom was 1 and P value was <0.001 .Contingency and Proportion table are shown below

Table 28

DRUG APNEA n value 95 % Confidence Interval
FENTOFOL Apnea 35 35/40 ( 87.5 %) 74.75% - 95.07%
FENTOFOL No_Apnea 5 5/40 ( 12.5 %) 4.93% - 25.25%
KETOFOL No_Apnea 40 40/40 ( 100 %) 93.95% - 100%

ADDITIONAL PROPOFOL REQUIRED

Figure 11 Distribution Of ADDITIONAL PROPOFOL REQUIREMENT IN TWO GROUPS

The Grouped Pie chart above represents individual counts representing frequency of PROPOFOL REQUIREment categories in categories FENTOFOL and KETOFOL . No Propofol requirement was seen in 29/40 ( 72.5 % ) in group FENTOFOL .No Propofol requirement was seen in 37/40 ( 92.5 % ) in group KETOFOLL . To formally check for association between groups we performed pearson chi-square test .

we found a Significant association between ADDITIONAL_PROPOFOL_REQUIRED and DRUG. The chi-square statistic was 4.24 . The degree of freedom was 1 and P value was 0.04 .Contingency and Proportion table are shown below

Table 29

DRUG ADDITIONAL_PROPOFOL_REQUIRED n value 95 % Confidence Interval
FENTOFOL No 29 29/40 ( 72.5 %) 57.45% - 84.42%
FENTOFOL Yes 11 11/40 ( 27.5 %) 15.58% - 42.55%
KETOFOL No 37 37/40 ( 92.5 %) 81.32% - 97.84%
KETOFOL Yes 3 3/40 ( 7.5 %) 2.16% - 18.68%

Table 30

FENTOFOL KETOFOL
No 29 37
Yes 11 3